{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:51:26Z","timestamp":1787727086779,"version":"build-2784847793"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In May 2018, the US Preventive Services Task Force (USPSTF) recommended prostate cancer (PCa) screening for ages 55\u201369 be an individual decision. This changed from the USPSTF's May 2012 recommendation against screening for all ages. The effects of the 2012 and 2018 updates on pathologic outcomes after prostatectomy are unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 647 patients with PCa who underwent prostatectomy at our institution from 2005 to 2018. Patient groups were those diagnosed before the 2012 update (<jats:italic>n<\/jats:italic>\u2009=\u2009179), between 2012 and 2018 updates (<jats:italic>n<\/jats:italic>\u2009=\u2009417), and after the 2018 update (<jats:italic>n<\/jats:italic>\u2009=\u200951). We analyzed changes in the age of diagnosis, pathologic Gleason grade group (pGS), pathologic stage, lymphovascular invasion (LVI), and favorable\/unfavorable pathology. Multivariable logistic regression adjusting for pre\u2010biopsy covariables (age, prostate\u2010specific antigen [PSA], African American race, family history) assessed impacts of 2012 and 2018 updates on pGS and pathologic stage. A <jats:italic>p\u2009<\/jats:italic>\u00a0&lt;\u20090.05 was statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median age increased from 60 to 63 (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) between 2012 and 2018 updates and to 64 after the 2018 update. A significant decrease in pGS1, pGS2, pT2, and favorable pathology (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and a significant increase in pGS3, pGS4, pGS5, pT3a, and unfavorable pathology (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) was detected between 2012 and 2018 updates. There was no significant change in pT3b or LVI between 2012 and 2018 updates. On multivariable regression, diagnosis between 2012 and 2018 updates was significantly associated with pGS4 or pGS5 and pT3a (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Diagnosis after the 2018 update was significantly associated with pT3a (<jats:italic>p<\/jats:italic>\u2009=\u20090.005). Odds of pGS4 or pGS5 were 3.2\u00d7 higher (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) if diagnosed between 2012 and 2018 updates, and 2.3\u00d7 higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.051) if after the 2018 update. Odds of pT3a were 2.4\u00d7 higher (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) if diagnosed between 2012 and 2018 updates and 2.9\u00d7 higher (<jats:italic>p<\/jats:italic>\u2009=\u20090.005) if after the 2018 update.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The 2012 USPSTF guidelines negatively impacted pathologic outcomes after prostatectomy. Patients diagnosed between 2012 and 2018 updates had increased frequency of higher\u2010risk PCa and lower frequency of favorable disease. In addition, data after the 2018 update demonstrate a continued negative impact on postprostatectomy pathology. Thus, further investigation of the long\u2010term effects of the 2018 USPSTF update is warranted.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pros.24261","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T14:13:16Z","timestamp":1637590396000},"page":"216-220","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of the 2012 and 2018 US preventive services task force prostate cancer screening guidelines on pathologic outcomes after prostatectomy"],"prefix":"10.1002","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-9647","authenticated-orcid":false,"given":"Benjamin D.","family":"Plambeck","sequence":"first","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke L.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Mcgirr","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant J.","family":"Van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad A.","family":"Lagrange","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna L.","family":"Boyle","sequence":"additional","affiliation":[{"name":"Department of Surgery,\u00a0Division of Urologic Surgery University of Nebraska Medical Center  Omaha Nebraska USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-2-201207170-00459"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15051"},{"issue":"3","key":"e_1_2_8_4_1","first-page":"102","article-title":"A trend toward aggressive prostate cancer","volume":"22","author":"Shah N","year":"2020","journal-title":"Rev Urol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1616281"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000383"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.6310"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3710"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2407-3"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2018.03.001"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.07.099"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.06.059"},{"issue":"3","key":"e_1_2_8_14_1","first-page":"171","article-title":"Impact of the US Preventive Services Task Force grade D recommendation: assessment of evaluations for elevated prostate\u2010specific antigen and prostate biopsies in a large urology group practice following statement revision","volume":"17","author":"McGinley KF","year":"2015","journal-title":"Rev Urol"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14866"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.09.017"},{"issue":"1","key":"e_1_2_8_17_1","first-page":"1","article-title":"Prostate biopsy features: a comparison between the pre\u2010 and post\u20102012 United States Preventive Services Task Force prostate cancer screening guidelines with emphasis on African American and septuagenarian men","volume":"21","author":"Shah N","year":"2019","journal-title":"Rev Urol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.03.171"},{"issue":"2","key":"e_1_2_8_19_1","article-title":"Active surveillance can reduce overtreatment in patients with low\u2010risk prostate cancer","volume":"60","author":"Thomsen FB","year":"2013","journal-title":"Dan Med J"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.11.095"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.24261","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pros.24261","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.24261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:27:54Z","timestamp":1693196874000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.24261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1002\/pros.24261"],"URL":"https:\/\/doi.org\/10.1002\/pros.24261","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"2021-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}